AUSTIN, TX, September 24, 2026 — Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced an upcoming presentation of results from its previously completed… The post Ollin Biosciences Announces Presentations and Symposium at EURETINA 2026 appeared first on Ollin Bio .